Regulation of Egr-1 by association with the proteasome component C8.

[1]  Y. M. Lee,et al.  Jab1 Interacts Directly with HIF-1α and Regulates Its Stability* , 2002, The Journal of Biological Chemistry.

[2]  S. Ryu,et al.  Binding and regulation of HIF‐1α by a subunit of the proteasome complex, PSMA7 , 2001 .

[3]  A. Ciechanover,et al.  The ubiquitin system , 2000, Nature Medicine.

[4]  L. Poellinger,et al.  Mechanism of regulation of the hypoxia‐inducible factor‐1α by the von Hippel‐Lindau tumor suppressor protein , 2000, The EMBO journal.

[5]  A. Paterson,et al.  Human Sug1/p45 is involved in the proteasome-dependent degradation of Sp1. , 2000, The Biochemical journal.

[6]  Zongyi Hu,et al.  Structural and Functional Characterization of Interaction between Hepatitis B Virus X Protein and the Proteasome Complex* , 2000, The Journal of Biological Chemistry.

[7]  Y. M. Lee,et al.  Egr-1 mediates transcriptional activation of IGF-II gene in response to hypoxia. , 1999, Cancer research.

[8]  Y. Zou,et al.  Hypoxia-associated Induction of Early Growth Response-1 Gene Expression* , 1999, The Journal of Biological Chemistry.

[9]  S. Salghetti,et al.  Destruction of Myc by ubiquitin‐mediated proteolysis: cancer‐associated and transforming mutations stabilize Myc , 1999, The EMBO journal.

[10]  J. Schwartz,et al.  Growth Hormone Stimulates Phosphorylation and Activation of Elk-1 and Expression of c-fos, egr-1, andjunB through Activation of Extracellular Signal-regulated Kinases 1 and 2* , 1998, The Journal of Biological Chemistry.

[11]  J. Drazen,et al.  cAMP-response-element-binding-protein-binding protein (CBP) and p300 are transcriptional co-activators of early growth response factor-1 (Egr-1). , 1998, The Biochemical journal.

[12]  W. D. de Jong,et al.  Structure and assembly of the 20S proteasome , 1998, Cellular and Molecular Life Sciences CMLS.

[13]  K. W. Kim,et al.  Insulin-like growth factor II induced by hypoxia may contribute to angiogenesis of human hepatocellular carcinoma. , 1998, Cancer research.

[14]  A. Varshavsky.  The ubiquitin system. , 1997, Trends in biochemical sciences.

[15]  J. Coligan,et al.  ATF-2 and C/EBPalpha can form a heterodimeric DNA binding complex in vitro. Functional implications for transcriptional regulation. , 1997, The Journal of biological chemistry.

[16]  Tom Maniatis,et al.  Regulation of Interferon-γ-Activated STAT1 by the Ubiquitin-Proteasome Pathway , 1996, Science.

[17]  D. Jackson,et al.  The insulin-like growth factor II/mannose 6-phosphate receptor is required for proliferin-induced angiogenesis. , 1996, Endocrinology.

[18]  J. Milbrandt,et al.  NAB2, a corepressor of NGFI-A (Egr-1) and Krox20, is induced by proliferative and differentiative stimuli , 1996, Molecular and cellular biology.

[19]  P. Howley,et al.  In vivo ubiquitination and proteasome-mediated degradation of p53(1). , 1996, Cancer research.

[20]  S. Gullans,et al.  Urea Inducibility of egr-1 in Murine Inner Medullary Collecting Duct Cells Is Mediated by the Serum Response Element and Adjacent Ets Motifs* , 1996, The Journal of Biological Chemistry.

[21]  A. Ciechanover,et al.  Degradation of the proto-oncogene product c-Fos by the ubiquitin proteolytic system in vivo and in vitro: identification and characterization of the conjugating enzymes , 1995, Molecular and cellular biology.

[22]  D. Mercola,et al.  Egr-1 negatively regulates human tumor cell growth via the DNA-binding domain. , 1995, Cancer research.

[23]  R. Figlin,et al.  Expression patterns of immediate early transcription factors in human non-small cell lung cancer. The Lung Cancer Study Group. , 1995, Oncogene.

[24]  J. Milbrandt,et al.  Identification of NAB1, a repressor of NGFI-A- and Krox20-mediated transcription. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[25]  J. Seo,et al.  Differential expression of transforming growth factor a and insulin-like growth factor II in chronic active hepatitis B, cirrhosis and hepatocellular carcinoma , 1995 .

[26]  L. Staszewski,et al.  Ubiquitin-dependent c-Jun degradation in vivo is mediated by the δ domain , 1994, Cell.

[27]  J. Sussenbach,et al.  Differential promoter activation in two human insulin-like growth factor-II-producing tumor cell lines. , 1993, Endocrinology.

[28]  Y. Tan,et al.  Regulation of the Egr-1 gene by tumor necrosis factor and interferons in primary human fibroblasts. , 1992, The Journal of biological chemistry.

[29]  G. Evan,et al.  Identification and characterisation of the egr-1 gene product as an inducible, short-lived, nuclear phosphoprotein. , 1990, Oncogene.

[30]  V. Rangnekar,et al.  Suppression of growth and transformation and induction of apoptosis by EGR-1. , 1998, Cancer gene therapy.

[31]  V. Sukhatme,et al.  Early growth response protein 1 (Egr-1): prototype of a zinc-finger family of transcription factors. , 1995, Progress in nucleic acid research and molecular biology.